LVDTX
LVDTX, licence 80030794: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Livdetox
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80030794
- Status
- Inactive licence
- Licence date
- 26 March 2012
- Revision date
- 15 March 2022
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sel interne d'hydroxyde de (carboxyméthyl)triméthylammonium Source : Chlorhydrate de bétaine | 19.0 mg | Not calculated |
| Lécithine Source : Glycine max - Graine | 25.0 mg | Not calculated |
| Silybum marianum Source : Seed (standardized extract) Extract : Matériel brut sec Potency : 80.0 % Silymarin | 16.7 mg | Not calculated |
| Taraxacum officinale Source : Feuille | 16.7 mg | Not calculated |
| Niacine Source : Acide nicotinique | 3.3 mg | Not calculated |
| Curcuma longa Source : Rhizome | 16.7 mg | Not calculated |
| 2-hydroxy-N,N,N-triméthyléthanaminium Source : Bitartrate de choline | 235.0 mg | Not calculated |
Non-medicinal ingredients
Silice, Hypromellose, Stéarate de magnésium végétal, cellulose, Acide stéarique, Silicate de magnésium, Croscarmellose de sodium, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Comprimé | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support liver function. A factor in the maintenance of good health. Helps to maintain the body's ability to metabolize nutrients. Helps to support the function of the liver, an organ involved in detoxification.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80030794
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.